scholarly journals HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one week schedule in Adjuvant breast cancer: An open-label randomised controlled study (HYPORT- Adjuvant): study protocol for a multicenter, randomized phase III trial.

Authorea ◽  
2020 ◽  
Author(s):  
Sanjoy Chatterjee ◽  
santam chakraborty ◽  
HYPORT Adjuvant Author Group
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Phase Iii ◽  
Controlled Study ◽  
Open Label ◽  
Phase Iii Trial ◽  
Randomised Controlled Study ◽  
Adjuvant Breast Cancer ◽  
Randomised Controlled ◽  
Hypofractionated Radiation

Postoperative Adjuvant Anastrozole for 10 Rather than 5 Years in Patients with Oestrogen Receptor-Positive Breast Cancer: AERAS, a Randomised Multicentre Open-Label Phase III Trial

2021 ◽  
Author(s):  
Takuji Iwase ◽  
Shigehira Saji ◽  
Kotaro Iijima ◽  
Kenji Higaki ◽  
Shoichiro Ohtani ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Oestrogen Receptor ◽  
Phase Iii ◽  
Open Label ◽  
Phase Iii Trial ◽  
Open Label Phase ◽  
Positive Breast Cancer

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

2010 ◽  
Author(s):  
H Joensuu ◽  
P-L Kellokumpu-Lehtinen ◽  
R Huovinen ◽  
A Jukkola-Vuorinen ◽  
M Tanner ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Early Breast Cancer ◽  
Phase Iii ◽  
Open Label ◽  
Phase Iii Trial ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document